Literature DB >> 19016529

Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.

Maelig Morvan1, Gaëlle David, Véronique Sébille, Aurore Perrin, Katia Gagne, Catherine Willem, Nolwenn Kerdudou, Laure Denis, Béatrice Clémenceau, Gilles Folléa, Jean-Denis Bignon, Christelle Retière.   

Abstract

NK-cell function is regulated by a balance between inhibitory and activating killer cell immunoglobulin-like receptors (KIR) that specifically recognize HLA class I molecules. Using KIR-specific mAb to discriminate between KIR2DS1 and KIR2DL1 receptors, we show that KIR2DS1(+) NK cells are C2-alloreactive only from C2(-) individuals. Moreover, using an in vitro model of NK-cell expansion, we show here that the frequency of KIR2DL1(+) NK cells is significantly higher in the absence of C2 ligand on stimulator EBV-B cells than in its presence. This observation was made regardless of the presence or absence of the autologous C2 ligand, suggesting that the C2(-) EBV-B stimulator cells used in this in vitro model could activate unlicensed KIR2DL1(+) NK cells. In the case of KIR2DL1(+)/S1(+) genotyped individuals, KIR2DS1(+) NK-cell frequency was increased after stimulation with C2(+) compared with C2(-) stimulator B cells, but only from C2(-) individuals. Altogether, these data highlight the C2 alloreactivity of KIR2DS1(+) NK cells that is only observed in C2(-) individuals. These results provide new insights into the way in which NK KIR cell expansion might be regulated in an allogeneic environment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016529     DOI: 10.1002/eji.200838407

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.

Authors:  Susan E Hiby; Richard Apps; Andrew M Sharkey; Lydia E Farrell; Lucy Gardner; Arend Mulder; Frans H Claas; James J Walker; Christopher W Redman; Christopher C Redman; Linda Morgan; Clare Tower; Lesley Regan; Gudrun E Moore; Mary Carrington; Ashley Moffett
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 2.  Challenges of NK cell-based immunotherapy in the new era.

Authors:  Fang Fang; Weihua Xiao; Zhigang Tian
Journal:  Front Med       Date:  2018-07-25       Impact factor: 4.592

3.  Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI).

Authors:  P Rettman; F Malard; N Legrand; O Avinens; J-F Eliaou; C Picard; A Dormoy; X Lafarge; M de Matteis; A Kennel; P Loiseau; A Devys; A Boudifa; L Absi; M Fort; D Masson; F Quainon; I Theodorou; A Batho; A Parissiadis; F Delbos; M Drouet; D Senitzer; E Marry; N Raus; I Yakoub-Agha; A Cesbron; C Retière; K Gagne
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

Review 4.  Future directions of clinical laboratory evaluation of pregnancy.

Authors:  Kenneth D Beaman; Mukesh K Jaiswal; Svetlana Dambaeva; Alice Gilman-Sachs
Journal:  Cell Mol Immunol       Date:  2014-07-21       Impact factor: 11.530

5.  Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I.

Authors:  Achim K Moesta; Thorsten Graef; Laurent Abi-Rached; Anastazia M Older Aguilar; Lisbeth A Guethlein; Peter Parham
Journal:  J Immunol       Date:  2010-08-27       Impact factor: 5.422

6.  Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.

Authors:  Veronika Bachanova; Daniel J Weisdorf; Tao Wang; Steven G E Marsh; Elizabeth Trachtenberg; Michael D Haagenson; Stephen R Spellman; Martha Ladner; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller; Sarah A Cooley
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-21       Impact factor: 5.742

7.  Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.

Authors:  Gaëlle David; Maelig Morvan; Katia Gagne; Nolwenn Kerdudou; Catherine Willem; Anne Devys; Marc Bonneville; Gilles Folléa; Jean-Denis Bignon; Christelle Retière
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

8.  Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.

Authors:  N Legrand; G David; C Retière; C Allavena; A Rodallec; A Gaultier; D Salmon; A Cesbron; L Wittkop; F Raffi; K Gendzekhadze; K Gagne
Journal:  Clin Exp Immunol       Date:  2021-02-02       Impact factor: 5.732

Review 9.  Activating killer cell Ig-like receptors in health and disease.

Authors:  Martin A Ivarsson; Jakob Michaëlsson; Cyril Fauriat
Journal:  Front Immunol       Date:  2014-04-22       Impact factor: 7.561

10.  Role of KIR3DS1 in human diseases.

Authors:  Christian Körner; Marcus Altfeld
Journal:  Front Immunol       Date:  2012-11-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.